News & stories Research news Promising trial of drug to treat low grade serous ovarian cancer 29 September 2019 There have been promising results from a trial for low grade ovarian cancer, revealed at the ESMO conference 2019 (European Society for Medical Oncology). The randomised trial of a drug called trametinib – previously used to treat melanoma – was shown to have an increased response rate compared with standard treatments. Read more here Further information Manage Cookie Preferences